BMY
Bristol Myers Squibb CoCompany with tickers: BMY, CELG-RI
CIK
14272
CUSIP
110122108
Shares Outstanding
2,042,071,247
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $11,489,000,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $2,649,000,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Operating Income | — | ||||
| Net Income | $2,677,000,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| EPS (Basic) | $1.31 | USD/shares | 2026-03-31 | 10-Q | 2026-04-30 |
| EPS (Diluted) | $1.31 | USD/shares | 2026-03-31 | 10-Q | 2026-04-30 |